BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
News on Divis Laboratories
Super Six short term picks for December 05
8.31 am | 05 Dec 2013 | Source: CNBC-TV18
Hemen Kapadia of KR Choksey Securities advises selling Divis Laboratories with a target of Rs 1122 and buying Wipro with a target of Rs 499....
Innovator forever: K Anji Reddy
4.35 pm | 22 Nov 2013 | Source: Forbes India
With his consistent focus on new ideas, K Anji Reddy encouraged several of his colleagues to start their own businesses....
IIFL's best bet from 'promising pharma' space
12.38 pm | 18 Nov 2013 | Source: CNBC-TV18
Bino Pathiparampil, vice president research, Institutional Equities picks Sun Pharma as his top pick in the sector, but is cautious on Lupin as he see...
Buy Divis Laboratories: Vishal Malkan
1.53 pm | 12 Nov 2013 | Source: CNBC-TV18
Vishal B Malkan of malkansview.com recommends buying Divis Laboratories as the stock may test Rs 1250....
Divis Laboratories Q2 net up 74% at Rs 205cr
1.22 pm | 09 Nov 2013 | Source: PTI
Net sales of Divis Laboratories rose to Rs 565.88 crore in second quarter ended September 30, as against Rs 472.60 crore in the same period of previou...
Divis Laboratories' Q2 results on Nov 08, 2013
11.51 am | 28 Oct 2013 | Source: Moneycontrol.com
Divis Laboratories Ltd has informed that a meeting of the Board of Directors of the Company will be held on November 08, 2013, to consider and approve...
Quick Links for Divis Laboratories
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.